Literature DB >> 6467991

Cytogenetic analysis of retinoblastoma: evidence for multifocal origin and in vivo gene amplification.

E Chaum, R M Ellsworth, D H Abramson, B G Haik, F D Kitchin, R S Chaganti.   

Abstract

Retinoblastoma (Rb) is an uncommon childhood tumor of the neural retina with a significant genetic component in its etiology. A small proportion of patients have a deletion in chromosome 13 encompassing band 13q14, an observation which permitted the assignment of the RB1 locus to this region. About 20% of Rb tumors exhibit microscopic deletions of band 13q14 or monosomy 13. Trisomy 1q and i(6p) have also been reported in a high percentage of tumors. We analyzed the chromosome complements from direct preparations of 10 Rb tumors derived from seven patients. Modal chromosome numbers ranged from 45 to 48, and occasional duplications of the genomes were noted. In general, the tumors were chromosomally stable, although karyotypic evolution and random chromosome loss were encountered. Consistent abnormalities included trisomy 1q, i(6p), 6q-, and del(13)(q12----14). One patient with bilateral Rb had three tumor clones (two in one eye and one in the other) with chromosome abnormalities unrelated in origin. A second patient with unilateral Rb had two tumor clones with chromosome abnormalities again unrelated in origin. These two patients provide some of the first cytogenetic evidence for the multifocal origin of primary Rb. In the untreated tumor of a third patient, a homogeneously staining region (HSR) was detected in 1p32, indicating gene amplication in vivo; previously, an HSR at this site has been reported in the established Rb cell line Y79.

Entities:  

Mesh:

Year:  1984        PMID: 6467991     DOI: 10.1159/000132037

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  7 in total

1.  Clinical implications of promoter hypermethylation in RASSF1A and MGMT in retinoblastoma.

Authors:  Kwong Wai Choy; Tom C Lee; Kin Fai Cheung; Dorothy S P Fan; Kwok Wai Lo; Katherine L Beaverson; David H Abramson; Dennis S C Lam; Christopher B O Yu; Chi Pui Pang
Journal:  Neoplasia       Date:  2005-03       Impact factor: 5.715

2.  Epidemiology and Rb1 gene of retinoblastoma.

Authors:  Jun Yun; Yang Li; Chang-Tai Xu; Bo-Rong Pan
Journal:  Int J Ophthalmol       Date:  2011-02-18       Impact factor: 1.779

3.  Linkage analysis of families with hereditary retinoblastoma: nonpenetrance of mutation, revealed by combined use of markers within and flanking the RB1 gene.

Authors:  H Scheffer; G J te Meerman; Y C Kruize; A H van den Berg; D P Penninga; K E Tan; D J der Kinderen; C H Buys
Journal:  Am J Hum Genet       Date:  1989-08       Impact factor: 11.025

4.  A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma.

Authors:  J Squire; B L Gallie; R A Phillips
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

5.  Comparative genomic hybridisation divides retinoblastomas into a high and a low level chromosomal instability group.

Authors:  J E van der Wal; M A J A Hermsen; H J P Gille; N Y N Schouten-Van Meeteren; A C Moll; S M Imhof; G A Meijer; J P A Baak; P van der Valk
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

6.  Destruction of human retinoblastoma after treatment by the E variant of encephalomyocarditis virus.

Authors:  Masazumi Adachi; Steven E Brooks; Maxine R Stein; Bernice E Franklin; Francis A Caccavo
Journal:  J Neurooncol       Date:  2006-05       Impact factor: 4.130

7.  RB1 gene inactivation by chromothripsis in human retinoblastoma.

Authors:  Justina McEvoy; Panduka Nagahawatte; David Finkelstein; Jennifer Richards-Yutz; Marcus Valentine; Jing Ma; Charles Mullighan; Guangchun Song; Xiang Chen; Matthew Wilson; Rachel Brennan; Stanley Pounds; Jared Becksfort; Robert Huether; Charles Lu; Robert S Fulton; Lucinda L Fulton; Xin Hong; David J Dooling; Kerri Ochoa; Elaine R Mardis; Richard K Wilson; John Easton; Jinghui Zhang; James R Downing; Arupa Ganguly; Michael A Dyer
Journal:  Oncotarget       Date:  2014-01-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.